Dr. Channing J. Paller, M.D.

Clinical Trials

• A Phase I Study of PCUR-101 in Combination With Androgen Suppression Therapy in the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
• Dose Escalating Trial of Mistletoe Extract in Patients With Advanced Solid Tumors
• Ph 2 Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC
• Study of TGF-? Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer

Media Releases

Get to know Oncologist Dr. Channing J. Paller, who serves patients in Baltimore, Maryland.

Dr. Paller is a top professional in the field of oncology, with a distinguished career marked by a commitment to innovative research and compassionate patient care. Her specialization encompasses a broad spectrum of urological cancers, including prostate, bladder, kidney, and testicular cancer, where her profound understanding and skillful approach make a tangible difference in the lives of her patients.

Currently she serves as Director of Prostate Cancer Clinical Research and an Associate Professor of Oncology at Johns Hopkins University School of Medicine. She shares her love of clinical research  with the community as the Associate Director of Oncology for the Johns Hopkins Clinical Research Network. She also is on the executive committee for the DOD funded Prostate Cancer Clinical Trial Consortium. She is co-PI for the PROMISE registry, providing free genetic testing and counseling for 5000 men with prostate cancer in the US. The registry provides education and clinical trial opportunities for men with genetic mutations: Prostatecancerpromise.org. 

Education-wise, Dr. Paller’s journey towards becoming a renowned oncologist began with the acquisition of her medical degree from Harvard Medical School, followed by a residency in internal medicine and a fellowship in oncology at the Johns Hopkins University School of Medicine.

Alongside her clinical training, she sought diverse experiences to enrich her understanding of cancer research and treatment modalities. She embarked on rotations at prominent institutions such as the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and the Food and Drug Administration, where she honed her expertise in investigational drug evaluation and regulatory science.

Passionate about her profession, Dr. Paller is board-certified in medical oncology and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Committed to excellence extends beyond her clinical practice, Dr. Paller is an active member of the American Society of Clinical Oncology and the American Association for Cancer Research. Through her membership in these esteemed organizations, she remains at the forefront of the latest advancements in oncology, continuously striving to enhance patient outcomes and elevate the standard of care. She serves on the executive committee for the Society of Integrative Oncology and has coauthored ASCO- SIO guidelines.

Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A medical professional who practices oncology is an oncologist. An oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. They lead a cancer treatment team of various healthcare professionals, including surgeons and radiation oncologists, coordinate treatment plans and prescribe various types of treatment, including chemotherapy and immunotherapy, as well as assist patients with pain management. 

In 2016, Dr. Paller was honored as one of only five oncologists nationwide to receive the prestigious NCI Mentored Patient-Oriented Research Career Development Award, a testament to her exceptional potential in shaping the future of cancer care. 

Prior to this, her groundbreaking contributions were acknowledged with the 2015 Passano Clinician Scientist Award, celebrating her early-stage research that has already begun to leave an indelible mark on the scientific community. Her remarkable achievements were further underscored by prestigious accolades such as the 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award, highlighting her promise as a trailblazer in the field. She has received grant funding from the National Institutes of Health, Department of Defense,  Prostate Cancer Foundation, and multiple other foundations.

More recently she has partnered with VA leadership to develop PROFOUND-VET- a network of clinicians and researchers working together to mine data to improve guidelines and care for Veterans.

Recommended Articles

• Why This Lymphoma Patient Has A New Lease on Life

  59-year-old Judy Wilkins, a mother of two and owner of a hair salon, had been battling lymphoma for years. The cancer became so aggressive that she tried four different chemotherapy regimens over a course of 18 months, with an aim to put it into remission. Nothing worked until CAR T-cell therapy....

• Diagnosing Colon Cancer

  Signs and symptoms of colon cancer are not specific, which makes it difficult to diagnose. Therefore, investigations are crucial to make a diagnosis of colon cancer.The first time you visit your doctor, he or she will record a complete medical history, including a detailed family history to check if...

• Overcoming Lymphoma: A South Philly Student's Story

  In April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...

• Advancements in Lymphedema Surgery After Breast Cancer

  Until now, many were relatively unaware that it is possible to treat severe cases of lymphedema with surgery, and the results are shown to be quite effective.What is lymphedema?Lymphedema is a chronic condition that is characterized by discomfort that results from lymph fluid collecting around where...

• “Cancer Anger” - An Explanation

  Following a cancer diagnosis, it is normal to be overwhelmed with a lot of different emotions. Some individuals may feel shocked and frightened, while others may feel sad, guilty, or upset. There is no right way to feel. ...

• Can Multiple Myeloma be Asymptomatic?

  Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...